期刊名：Hemato (ISSN 2673-6357)

期刊主页：https://www.mdpi.com/journal/hemato

我们诚挚邀请您一同回顾 Hemato 期刊精心汇编的 2024 年度 10 篇高质量论文。希望这份精选合集能为您在测量或者计量领域的科研工作带来新的启发与思路！所有文章均为开放获取，免费阅读。

【精选高质量论文推荐】

1.Neurovascular Manifestations of Sickle Cell Disease

镰状细胞病的神经血管表现

http://www.mdpi.com/2673-6357/5/3/23

2.Artificial Intelligence, Lymphoid Neoplasms, and Prediction of MYC, BCL2, and BCL6 Gene Expression Using a Pan-Cancer Panel in Diffuse Large B-Cell Lymphoma

人工智能、淋巴瘤以及利用泛癌基因检测预测弥漫性大B细胞淋巴瘤中MYC、BCL2和BCL6基因表达

http://www.mdpi.com/2673-6357/5/2/11

3.B- and T-/NK-Cell Lymphomas in the 2022 International Consensus Classification of Mature Lymphoid Neoplasms and Comparison with the WHO Fifth Edition

2022年国际成熟淋巴瘤共识分类中的B细胞和T/NK细胞淋巴瘤及其与WHO第五版分类的比较

http://www.mdpi.com/2673-6357/5/2/13

4.Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations

镰状细胞病住院患者的输血模式

http://www.mdpi.com/2673-6357/5/1/4

5.The Role of Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Multiple Myeloma: Is It Time to Rethink the Paradigm in the Era of Targeted Therapy?

自体干细胞移植在初诊多发性骨髓瘤治疗中的作用：在靶向治疗时代，是否应该重新思考治疗模式？

http://www.mdpi.com/2673-6357/5/1/5

6.Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis

外周血嗜酸性粒细胞增多症综述：检查和鉴别诊断

http://www.mdpi.com/2673-6357/5/1/8

7.The Role of Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Multiple Myeloma: Is It Time to Rethink the Paradigm in the Era of Targeted Therapy?

自体干细胞移植在初诊多发性骨髓瘤治疗中的作用：在靶向治疗时代，是否应该重新思考治疗模式？

http://www.mdpi.com/2673-6357/5/2/12

8.The Role of Machine Learning in the Most Common Hematological Malignancies: A Narrative Review

机器学习在最常见血液系统恶性肿瘤中的作用：叙述性综述

http://www.mdpi.com/2673-6357/5/4/27

9.The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax

新型抗癌药物 SpiD3 对伊布替尼或维奈托克耐药的慢性淋巴细胞白血病 (CLL) 细胞具有细胞毒性

http://www.mdpi.com/2673-6357/5/3/24

10.Real World Predictors, Timing, and Outcomes of Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

多发性骨髓瘤患者自体干细胞移植的真实世界预测因素、时机和预后

http://www.mdpi.com/2673-6357/5/4/30

期刊介绍

Hemato (ISSN 2673-6357) 是一个经国际同行评审的开放获取期刊，涵盖了血液学领域的各个方面，包括但不限于肿瘤和非肿瘤血液疾病的发病机制、诊断和治疗等。期刊目前已被 ESCI (Web of Science)、Scopus、EBSCO、CNKI、DOAJ等多个数据库收录。

2024 Impact Factor：1.0

2024 CiteScore：2.0

Time to First Decision：21.8 Days

Acceptance to Publication：3 Days